Risk Evaluation and Mitigation Strategies (REMS) Services
Risk Evaluation and Mitigation Strategies (REMS) Services
McKesson Specialty Care Solutions is managing some of the industry’s most complex and rigorous REMS programs mandated by the FDA. Our experienced team of clinical, safety, product launch, and data management experts are actively providing assistance to manufacturers through their REMS development process. We currently manage risk management programs across a spectrum of therapeutic areas, including oncology, opioids, rheumatology, neurology, pain management, and cardiovascular, among others.
Our deep expertise and broad range of capabilities enables us to provide customers with a unique, end-to-end REMS solution that meets FDA safety requirements for current programs while ensuring appropriate access to drugs and biologics. McKesson has the broad assets to design, implement, and manage all components of REMS, as demonstrated in our wide spectrum of capabilities.
Features
Consultation on FDA submissions, strategic program designs, and other consulting services
End-to-end program implementation
Validated registry with patient, physician, hospital, and pharmacy enrollment capabilities
Largest single-site call center in healthcare
Risk monitoring and clinical data collection by highly trained nurses
Assessment of program effectiveness through patient and provider surveys
Strong data management and safety reporting capabilities
Unparalleled program management and support team
Integration with reimbursement support services
Full range of distribution models
Ability to integrate with retail pharmacy solution
Rigorous program compliance monitoring and auditing
Clinical and regulatory expertise
Benefits
Reduce likelihood of drug launch delays by planning early and leveraging McKesson’s experience in designing REMS and working with the manufacturer to obtain FDA approval of the REMS program
Increase program efficiency by working with a partner that can meet all of a manufacturers’ REMS needs from program design, to implementation, to reporting, to distribution
Opportunity to ease the burden on physician offices by integrating manufacturers’ REMS and reimbursement/access programs and creating a “one-stop-shop” for their customers
Ensure adverse events are captured and tracked appropriately per manufacturer’s defined process in McKesson’s validated environment
REMS is defined by the FDA as a program to manage a known or potential serious risk associated with a drug or biologic product. A REMS program may include:
Medication guide
Communication plan
Elements to assure safe use
Implementation system
Restricted distribution
Timetable for assessment
Webinar Replay "Submitting a Proposed REMS: How to Comply with FDA Guidance"
Access the January 13, 2010 CBI webinar led by Heather Morel, Ravi Deshpande and Regina Murphy of McKesson.
Thought Leadership
Read the article "The Changing Face of Today's Patient Assistance Programs" in Pharmaceutical Commerce, with editorial contribution from VP/GM Heather Morel
Read the article "REMS Standards Created by NCPDP" by VP/GM Heather Morel in Pharmacy Times
Read the article "Ten REMS Throw Retirement Party" by VP/GM Heather Morel in Pharmacy Times
Read the byline article "Risk Evaluation and Mitigation Strategies in the Specialty BioPharma Market: What each stakeholder needs to know about REMS in today's fast-paced climate." by Heather Morel, VP/GM, Reimbursement & Access Services. Published October 12, 2010 in Specialty Pharmacy Times
Read the byline article "Smoothing the Path to Drug Safety" by Heather Morel and Ravi Deshpande, Pharm.D., McKesson Specialty Care Solutions in the June 2010 issue of Pharmaceutical Commerce.
Read the byline article "Dealing with REMS Challenges in Drug Commercializations" by VP/GM Heather Morel and Director of Product Development Regina Murphy in the August 2009 issue of Pharmaceutical Commerce.
McKesson Specialty Care Solutions is a featured sponsor/exhibitor at the 2nd Annual Global Pricing and Reimbursement Conference June 14-15. Visit the McKesson booth to learn about our Reimbursement Consulting Services which help manufacturers understand the reimbursement landscape and shape their commercialization strategies.